Long-term outcome of living donor liver transplantation for primary biliary cirrhosis

Transplant International

Volumn 25, Issue 1, 2012, Pages 7-12

  Kaneko, Junichi ^a   Sugawara, Yasuhiko ^a   Tamura, Sumihito ^a   Aoki, Taku ^a   Hasegawa, Kiyoshi ^a   Yamashiki, Noriyo ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

liver transplantation; living donor; pre emptive therapy; primary biliary cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; TACROLIMUS; URSODEOXYCHOLIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC GRAFT REJECTION; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; OSTEOPOROSIS; OVERALL SURVIVAL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SCREENING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROGNOSIS; RECURRENCE; TACROLIMUS; TREATMENT OUTCOME;

EID: 83955164239     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01336.x     Document Type: Article

References (42)

1. Lindor K,. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007; 357: 1524.
2. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485.
3. Brind AM, Bray GP, Portmann BC, Williams R,. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36: 615.
4. Kaplan MM, Gershwin ME,. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261.
5. Poupon R,. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010; 52: 745.
6. Murtaugh PA, Dickson ER, Van Dam GM, et al. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994; 20: 126.
7. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC,. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
8. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M,. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant 2005; 5: 1694.
9. Yamashiki N, Sugawara Y, Tamura S, et al. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transpl 2006; 12: 1077.
10. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317.
11. Tamura S, Sugawara Y, Kishi Y, et al. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: a single-center experience at the University of Tokyo. Transplant Proc 2004; 36: 3242.
12. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792.
13. Akamatsu N, Sugawara Y, Kaneko J, Kishi Y, Makuuchi M,. Risk factors of cytomegalovirus infection after living donor liver transplantation. Hepatogastroenterology 2005; 52: 197.
14. Hohenester S, Oude-Elferink RP, Beuers U,. Primary biliary cirrhosis. Semin Immunopathol 2009; 31: 283.
15. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM,. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18: 173.
16. Ludwig J, Dickson ER, McDonald GS,. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379: 103.
17. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M,. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C. Transplant Proc 2006; 38: 2989.
18. Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP,. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev 2009; 25: 705.
19. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R,. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306: 1.
20. Liermann RF, Evangelista Garcia C, McMaster P, Neuberger J,. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001; 33: 22.
21. Neuberger J, Gunson B, Hubscher S, Nightingale P,. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004; 10: 488.
22. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007; 3: 1236.
23. Jacob DA, Neumann UP, Bahra M, et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant 2006; 20: 211.
24. Sanchez EQ, Levy MF, Goldstein RM, et al. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003; 76: 1583.
25. Manousou P, Arvaniti V, Tsochatzis E, et al. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity. Liver Transpl 2010; 16: 64.
26. Sebagh M, Farges O, Dubel L, Samuel D, Bismuth H, Reynes M,. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 1998; 65: 1328.
27. Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL,. Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant 2010; 10: 852.
28. Morioka D, Egawa H, Kasahara M, et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80.
29. Guy JE, Qian P, Lowell JA, Peters MG,. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005; 11: 1252.
30. Silveira MG, Talwalkar JA, Lindor KD, Wiesner RH,. Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant 2010; 10: 720.
31. Guichelaar MM, Kendall R, Malinchoc M, Hay JE,. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 2006; 12: 1390.
32. Saab S, Shpaner A, Zhao Y, et al. Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation. Am J Transplant 2006; 6: 1890.
33. Kim WR, Wiesner RH, Therneau TM, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998; 28: 33.
34. Williams R, Gershwin ME,. How, why, and when does primary biliary cirrhosis recur after liver transplantation? Liver Transpl 2007; 13: 1214.
35. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC,. The pathology of liver allografts surviving longer than one year. Hepatology 1990; 11: 465.
36. Balan V, Ruppert K, Demetris AJ, et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology 2008; 48: 878.
37. Rautiainen H, Karkkainen P, Karvonen AL, et al. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology 2005; 41: 747.
38. Polson RJ, Portmann B, Neuberger J, Calne RY, Williams R,. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. Gastroenterology 1989; 97: 715.
39. Khettry U, Anand N, Faul PN, et al. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Liver Transpl 2003; 9: 87.
40. Levitsky J, Hart J, Cohen SM, Te HS,. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003; 9: 733.
41. Takeishi T, Sato Y, Ichida T, Yamamoto S, Kobayashi T, Hatakeyama K,. Short-term outcomes of living-related liver transplantation for primary biliary cirrhosis and its recurrence: report of five cases. Transplant Proc 2003; 35: 372. (Pubitemid 36194652)
42. Hashimoto E, Taniai M, Yatsuji S, et al. Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis. Hepatol Res 2007; 37: S455.